Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients
A completed clinical trial evaluated insulin glargine (Lantus) for beta-cell function support and cardiovascular protection in adults with t…
-
CLINICAL_TRIALS research · 2010-09-22Clinical Trial Update: Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus [Phase 4]
Clinical trial update evaluating switching from insulin therapy to a metformin and saxagliptin combination in patients with Type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2) [Phase 2]
This is a Phase 2 study of MK8245 in type 2 diabetes mellitus that was terminated, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluating the benefits of a blood glucose monitoring system in adults with type 2 diabetes; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: A Study for Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial in type 2 diabetes mellitus completed; results were posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-09-14FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) filed by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Dose Ranging Study With LT, Monotherapy, PPAR [Phase 2, Phase 3]
Bristol-Myers Squibb completed a dose-ranging study (Phase 2/Phase 3) of LT as monotherapy targeting PPAR in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone [Phase 3]
A Phase 3 clinical trial comparing muraglitazar to glimepiride in adults with type 2 diabetes not adequately controlled on metformin.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics [Phase 3]
A Phase 3 study evaluating combining metformin with muraglitazar or pioglitazone in Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes [Phase 3]
A Phase 3 trial update assessing muraglitazar for Type 2 diabetes, focusing on mechanism of action and efficacy; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes [Phase 3]
Phase 3 trial comparing muraglitazar to pioglitazone in adults with Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator [Phase 2]
Phase 2 placebo-controlled study of INT131 Besylate in Type 2 diabetes mellitus to evaluate safety and efficacy, with results posted in 2010…
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes [Phase 1]
Phase 1 study assessing safety, tolerability, and preliminary effects of multiple injections of LY2405319 in adults with Type 2 diabetes mel…
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus [Phase 4]
This Phase 4 trial evaluated the safety and effectiveness of Apidra (insulin glulisine) in combination with basal insulin in adults with Typ…
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: DOMME Dose Optimization Multicentric Mexican Evaluation [Phase 4]
Sanofi completed a Phase 4 multicenter dose-optimization study of DOMME for Type 2 diabetes in Mexico. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period [Phase 3]
A Phase 3 study comparing saxagliptin added to metformin with a sulphonylurea as add-ons, followed by a 52-week extension; the trial has com…
-
CLINICAL_TRIALS trial_result · 2010-09-02Clinical Trial Update: Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin [Phase 3]
Phase 3 trial evaluating the safety and efficacy of exenatide in patients with Type 2 Diabetes Mellitus using a thiazolidinedione, with or w…
-
CLINICAL_TRIALS trial_result · 2010-09-01Clinical Trial Update: Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure. [Phase 2]
A Phase 2 study assesses the efficacy of pioglitazone in combination with insulin in subjects with Type 2 diabetes mellitus and renal failur…
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement [Phase 4]
Phase 4 study evaluating an insulin analogue with continuous glucose monitoring in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus [Phase 4]
This is a Phase 4 clinical trial update evaluating Lantus (insulin glargine) dosing algorithms to achieve normal blood glucose targets in ad…
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial update evaluating a medical food in adults with Type 2 diabetes; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes [Phase 2]
Phase IIa proof-of-concept trial of NC-503 in adults with type 2 diabetes mellitus has been completed. The study was sponsored by Bellus Hea…
-
CLINICAL_TRIALS trial_result · 2010-08-23Clinical Trial Update: Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial compared Exenatide plus Metformin with Insulin Aspart plus Metformin in Type 2 Diabetes to assess glycemic control and hypog…
-
CLINICAL_TRIALS trial_result · 2010-08-23Clinical Trial Update: The Effect and Mechanisms of the Second-meal Phenomenon in Type 2 Diabetic Patients
This clinical trial update summarizes a completed study investigating the effects and underlying mechanisms of the second-meal phenomenon in…
-
CLINICAL_TRIALS research · 2010-08-19Clinical Trial Update: Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes [Phase 4]
Phase 4 clinical trial comparing Vytorin (simvastatin/ezetimibe) 10/20 mg versus atorvastatin 20 mg on the ApoB/ApoA1 ratio in adults with t…